Population Health Management Exam 1 IClicker Flashcards

1
Q

Dr. Scott practiced clinically at which of the following?

A. IU Arnett Hospital
B. Walgreens
C. Riley Children’s Hospital
D. Indiana University Hospital
E. CVS

A

C. Riley Children’s Hospital

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

All of the following is true about Dr. Scott’s interests EXCEPT:

A. Likes to read about history
B. Enjoys fishing
C. Is passionate about Purdue sports
D. Enjoys classical music
E. Has 4 grandchildren

A

B. Enjoys fishing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Dr. Scott served as president of which one of the following professional organizations?

A. American Pharmacists Association
B. American Society of Health-System Pharmacists
C. American Hospital Association
D. American Association of Colleges of Pharmacy

A

D. American Association of Colleges of Pharmacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Population health looks for differences in health outcomes among groups of patients in the general population or a population subset

True or False

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Health promotion and wellness programs (nutrition, exercise, meditation) are most appropriate and useful to implement in which of the following groups of patients on the care continuum?

A. No or low risk patients
B. Moderate risk patients
C. High risk patients

A

A. No or low risk patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

The easiest kind of data to acquire to use to identify population health issues is which of the following?

A. Claims data
B. EHR data
C. Satisfaction survey data
D. Medication adherence data
E. Socioeconomic data

A

A. Claims data

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

According to Healthy People 2020 data, the access to health services is NOT impacted by family income

True or False

A

False

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

In 2020, the leading cause of mortality for children ages 1-19 in the United States was which of the following?

A. Cancer
B. Motor vehicle accidents
C. Heart disease
D. Firearms
E. Congenital disorders

A

D. Firearms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Life expectancy, maternal mortality, and infant mortality data in the United States is superior to most other industrialized nations in the world.

True or False

A

False

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Dr. Zillich would be a great resource if you wanted to do which of the following?

A. Become a pastry chef
B. Write your first novel
C. Learn how to brew your own beer
D. Become a master gardener

A

C. Learn how to brew your own beer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Costs of pain and suffering are examples of intangible costs and are difficult to measure

True or False

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

A cost-minimization analysis is only useful when the outcomes are equal

True or False

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Which of the following is NOT an example of direct medical costs?

A. Medications
B. Lab Tests
C. Travel costs to hospital or clinic
D. Provider charges
E. Hospital Charges

A

C. Travel costs to hospital or clinic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

A cost-effectiveness analysis is commonly used to compare a new treatment to a standard treatment

True or False

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

When comparing two therapeutic agents in a pharmacoeconomic analysis, all costs associated with the drug (not just acquisition cost) should be taken into account

True or False

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which of the following types of PE analysis is used when you want to measure the quality of outcome produced and is usually measured in quality-adjusted life year?

A. Cost-benefit analysis
B. Cost-minimization analysis
C. Cost-utility analysis
D. Cost-effectiveness analysis

A

C. Cost-utility analysis

17
Q

*Which of the following is NOT a surrogate endpoint that is used to evaluate the potential benefits of using tirzepatide to treat patients with DM?

A. Reduction in CV mortality
B. Hgb A1c
C. Weight loss/ BMI
D. Fasting blood glucose

A

D. Fasting blood glucose

18
Q

The study of the utilization and effects of drugs in large numbers of people is best defined as:

A. Pharmacovigilance
B. Comparative effectiveness research
C. Pharmacoepidemiology
D. Pharmacoeconomics

A

C. Pharmacoepidemiology

19
Q

Which of the following is LEAST likely to identify how a drug or therapy will perform in real world settings?

A. Randomized Controlled Trials
B. Comparative Effectiveness Research
C. Pragmatic Clinical Trials

A

A. Randomized Controlled Trials

20
Q

Pharmacovigilance studies are used to identify undetected ADRs or safety-related aspects of marketed drugs not observed in premarketing studies

True or False

A

True

21
Q

Pharmacoepidemiologic and pharmacovigilance studies are primarily:

A. Experimental
B. Non-experimental (Observational)
C. Neither of the above

A

B. Non-experimental (Observational)

22
Q

A typical randomized controlled trial may determine the efficacy of a drug but may not determine if the drug will achieve its desired effect in a real-world setting

True or False

A

True

23
Q

RCTs have a higher degree of external validity than do Pragmatic Trials

True or False

A

False

24
Q

Pharmacovigilance studies typically use observational data from a single database from a small targeted population

True or False

A

False

25
Q

Which of the following complications associated with use of fluoroquinolones was teased out from data in post-marketing pharmacovigilance studies?

A. Blood dyscrasias
B. Electrolyte abnormalities
C. Disabling peripheral neuropathies/ myopathies
D. Skin rash

A

C. Disabling peripheral neuropathies/ myopathies

26
Q

The US spends significantly more money than other comparable countries on healthcare but achieves poorer outcomes

True or False

A

True

27
Q

Retail prescription drugs constitute the largest share (as a percentage) of all categories associated with national health expenditures

True or False

A

False

28
Q

Individuals > 50 years of age consume the largest share (about 50%) of healthcare spending in the US

True or False

A

True

29
Q

Which of the following is NOT a strength of the US healthcare system?

A. Well equipped healthcare facilities
B. Exceptionally trained healthcare professionals
C. Choice in providers
D. Transparency with respect to costs to patients
E. New technologies and therapeutic entities

A

D. Transparency with respect to costs to patients

30
Q

Which of the following factors currently accounts for the largest number of preventable deaths in the US?

A. Alcohol-related
B. Suicides
C. Drug overdoses
D. Deaths from communicable diseases

A

C. Drug overdoses

31
Q

Which of the following is NOT one of the major identity disclosures identified in the discussion paper by Keeler, et. al?

A. Dispenser
B. Apothecary
C. Health care provider
D. Druggist
E. Merchandiser

A

D. Druggist

32
Q

Except during the pandemic, the largest portion of public health financing and services comes from the federal government

True or False

A

True

33
Q

One of the reasons why drug costs are higher in the US than in other comparable countries is because the share of the prescriptions dispensed that are generic is far less in the US than in those other countries

True or False

A

False

34
Q

Which of the following is the most common type of insurance coverage in the US?

A. Self-insurance
B. Employer provided
C. Medicaid
D. Medicare
E. Medicare + Private insurance

A